ES2924289T3 - Ligandos amínicos tipo jaula para metalorradiofármacos - Google Patents
Ligandos amínicos tipo jaula para metalorradiofármacos Download PDFInfo
- Publication number
- ES2924289T3 ES2924289T3 ES12856044T ES12856044T ES2924289T3 ES 2924289 T3 ES2924289 T3 ES 2924289T3 ES 12856044 T ES12856044 T ES 12856044T ES 12856044 T ES12856044 T ES 12856044T ES 2924289 T3 ES2924289 T3 ES 2924289T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- optionally substituted
- formula
- compound
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/08—Copper compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161567262P | 2011-12-06 | 2011-12-06 | |
| PCT/AU2012/001484 WO2013082656A1 (en) | 2011-12-06 | 2012-12-06 | Cage amine ligands for metallo-radiopharmaceuticals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2924289T3 true ES2924289T3 (es) | 2022-10-05 |
Family
ID=48573413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12856044T Active ES2924289T3 (es) | 2011-12-06 | 2012-12-06 | Ligandos amínicos tipo jaula para metalorradiofármacos |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9457107B2 (enExample) |
| EP (2) | EP2788353B1 (enExample) |
| JP (1) | JP6047581B2 (enExample) |
| AU (1) | AU2012350147B2 (enExample) |
| DK (1) | DK2788353T3 (enExample) |
| ES (1) | ES2924289T3 (enExample) |
| PT (1) | PT2788353T (enExample) |
| WO (1) | WO2013082656A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2788353T3 (da) | 2011-12-06 | 2022-08-15 | Clarity Pharmaceuticals Ltd | Bur-aminligander til metallo-radiofarmaceutika |
| WO2013181697A1 (en) * | 2012-06-05 | 2013-12-12 | The University Of Melbourne | Bicyclo[6.1.0]non-4-yne compounds suitable for use as linkers in biological applications |
| US9597643B1 (en) * | 2013-10-22 | 2017-03-21 | U.S. Department Of Energy | Surface functionalization of metal organic frameworks for mixed matrix membranes |
| US9422286B2 (en) * | 2014-01-27 | 2016-08-23 | Washington University | Metal-binding bifunctional compounds as diagnostic agents for Alzheimer's disease |
| CA3066525A1 (en) | 2017-06-06 | 2018-12-13 | The University Of Melbourne | Radiopharmaceuticals, radioimaging agents, and uses thereof |
| CN111989324A (zh) * | 2018-04-11 | 2020-11-24 | 墨尔本大学 | 靶向化合物及其生产方法 |
| AU2019251769A1 (en) * | 2018-04-11 | 2020-10-15 | Clarity Pharmaceuticals Limited | Formulations and kits for radiotherapy and diagnostic imaging |
| TW202426433A (zh) | 2022-09-23 | 2024-07-01 | 瑞士商紐利迪姆股份公司 | 成纖維細胞活化蛋白（ｆａｐ）抑制劑、ｆａｐ結合物及其診斷與治療用途 |
| IL319722A (en) | 2022-09-23 | 2025-05-01 | Nuclidium Ag | High purity radionuclides and their diagnostic and medical uses |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0001719A1 (en) | 1977-10-26 | 1979-05-02 | The Australian National University | Metal complexes, their preparation and production of hydrogen peroxide therewith |
| WO1995031202A1 (en) | 1994-05-17 | 1995-11-23 | Commonwealth Scientific And Industrial Research Organisation | Cage compounds, processes for their preparation and their use as antiviral agents |
| EP1331012A1 (en) | 2002-01-29 | 2003-07-30 | BRACCO IMAGING S.p.A. | Responsive paramagnetic MRI contrast agents |
| FI20031528A0 (fi) | 2003-10-17 | 2003-10-17 | Ctt Cancer Targeting Tech Oy | Terapeuttinen liposomikoostumus ja menetelmä sen valmistamiseksi |
| ES2712881T3 (es) * | 2008-12-02 | 2019-05-16 | Univ Melbourne | Conjugados macrocíclicos que contienen nitrógeno como radiofármacos |
| WO2010121133A2 (en) * | 2009-04-17 | 2010-10-21 | The General Hospital Corporation | Multimodal imaging of fibrin |
| DK2788353T3 (da) | 2011-12-06 | 2022-08-15 | Clarity Pharmaceuticals Ltd | Bur-aminligander til metallo-radiofarmaceutika |
-
2012
- 2012-12-06 DK DK12856044.8T patent/DK2788353T3/da active
- 2012-12-06 ES ES12856044T patent/ES2924289T3/es active Active
- 2012-12-06 AU AU2012350147A patent/AU2012350147B2/en active Active
- 2012-12-06 PT PT128560448T patent/PT2788353T/pt unknown
- 2012-12-06 EP EP12856044.8A patent/EP2788353B1/en active Active
- 2012-12-06 WO PCT/AU2012/001484 patent/WO2013082656A1/en not_active Ceased
- 2012-12-06 US US14/363,219 patent/US9457107B2/en active Active
- 2012-12-06 JP JP2014545038A patent/JP6047581B2/ja active Active
- 2012-12-06 EP EP22173377.7A patent/EP4063369A1/en active Pending
-
2016
- 2016-08-18 US US15/240,836 patent/US9861714B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP6047581B2 (ja) | 2016-12-21 |
| EP2788353B1 (en) | 2022-05-18 |
| AU2012350147B2 (en) | 2017-08-03 |
| WO2013082656A1 (en) | 2013-06-13 |
| JP2015500247A (ja) | 2015-01-05 |
| US20140323718A1 (en) | 2014-10-30 |
| US9457107B2 (en) | 2016-10-04 |
| EP2788353A1 (en) | 2014-10-15 |
| EP4063369A1 (en) | 2022-09-28 |
| US20160354497A1 (en) | 2016-12-08 |
| PT2788353T (pt) | 2022-08-12 |
| US9861714B2 (en) | 2018-01-09 |
| AU2012350147A1 (en) | 2014-07-03 |
| EP2788353A4 (en) | 2015-04-22 |
| DK2788353T3 (da) | 2022-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2712881T3 (es) | Conjugados macrocíclicos que contienen nitrógeno como radiofármacos | |
| ES2943458T3 (es) | Radiofármacos, agentes de radioimagen y usos de los mismos | |
| JP6047581B2 (ja) | 金属放射性医薬品のためのケージアミン配位子 | |
| US9364570B2 (en) | Functionalisation of cage amine ligands for metallo-radiopharmaceuticals | |
| HK40080888A (en) | Cage amine ligands for metallo-radiopharmaceuticals |